# Role of skeletal muscle stem cell fusion and fibrosis during aging

> **NIH NIH R01** · CINCINNATI CHILDRENS HOSP MED CTR · 2022 · $349,800

## Abstract

Project Summary/Abstract
Sarcopenia is a devastating skeletal muscle condition that occurs in advanced age and due to various chronic
conditions. Despite the widespread prevalence of sarcopenia there are no treatment options and the
mechanisms underlying this process are not completely understood. Hallmark characteristics of skeletal
muscle aging are a reduction in myofiber size and number, dysregulated muscle function, and an increased
incidence of fibrosis. An additional process altered during aging is the activity of muscle stem cells (MuSCs),
which typically are quiescent but in a young environment function to fully repair damaged muscle and allow
muscle to adapt to external stimuli. Although MuSCs are clearly required for development and regeneration,
we still do not understand their exact role during muscle homeostasis and aging. To this end, we have
generated a unique mouse model that ablates MuSC fusion activity but maintains their presence within the
tissue. Our recent studies showed that MuSC fusion is required for muscle growth in a young environment,
and that without MuSC fusion, pronounced development of fibrosis ensues. Moreover, our preliminary data
indicate that MuSC fusion is dysregulated in aged skeletal muscle. Thus, we hypothesize that fusion of
MuSCs with myofibers is necessary to maintain myofiber integrity, and dysregulation of this process leads to
pathological extracellular matrix (ECM) remodeling during aging. To definitively answer these questions, we
have generated numerous novel genetic reagents to manipulate both MuSC fusion and fibrosis in vivo. Based
on these preliminary data and unique mouse models we propose to comprehensively determine the role for
MuSCs and evaluate the consequences of fibrosis development during skeletal muscle aging. Specifically, we
propose to: 1) elucidate the requirement of MuSC fusion for muscle adaptation during aging 2) molecularly
dissect the mechanisms of fusion in aged skeletal muscle and 3) define the relationship between fibrosis and
MuSC fusion during the development of sarcopenia. Successful completion of these studies will provide unique
insight into the general mechanisms of MuSC-dependent muscle aging and provide new knowledge that will
identify new therapeutic strategies to combat sarcopenia.

## Key facts

- **NIH application ID:** 10375373
- **Project number:** 5R01AG059605-05
- **Recipient organization:** CINCINNATI CHILDRENS HOSP MED CTR
- **Principal Investigator:** Douglas Paul Millay
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $349,800
- **Award type:** 5
- **Project period:** 2018-07-15 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10375373

## Citation

> US National Institutes of Health, RePORTER application 10375373, Role of skeletal muscle stem cell fusion and fibrosis during aging (5R01AG059605-05). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10375373. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*